NOV 14, 2018 9:00 AM PST

Accelerating Cancer Research and Clinical Innovations Using OncoLand

Sponsored by: QIAGEN
Speaker
  • Sr. Scientist, Bioinformatics, QIAGEN
    Biography
      Dr. Zhou is a professional scientist with more than 10 years of experience in oncology, cancer genetics, and preclinical drug discovery. She previously works as research associate in the Lineberger Cancer Center of University of Carolina at Chapel Hill, where her interests are centered around molecular mechanisms of breast cancer and prostate cancer using animal models. Her experiences in industry includes target discovery and validation, cell-based assay development, and small molecules screening. Currently, Bing is managing Oncoland curation team within OmicSoft, a QIAGEN company. So far, OncoLand curation team has curated thousands of projects from cancer genomics consortia as well as public data repositories. Her knowledge on cancer biology and clinical ontologies has supported the establishment of internal curation standards.

    Abstract

    With significant decrease in the cost of sequencing in numerous commercial as well as cancer center–driven initiatives, genomic profiling is increasingly becoming routine across multiple cancer types. There is a large amount of diverse omic-data that has been generated, which are either publicly accessible through numerous repositories or managed through controlled data archives. However, the sheer volume and diversity of the data presents a significant challenge in data management and analysis. 

    OncoLand is an integrated oncology genomics repository and visualization platform. Feature tremendous numbers of consortia data and tens of thousands of processed and carefully curated cancer genomics datasets from public domains. The OncoLand tool enables investigators to easily query and navigate a gene or sets of genes of interest in multiple tumors across data from different platforms, including DNA mutation, gene expression and fusion, copy number, protein, and methylation. The built-in Omicsoft Genome Browser (OGB) allows a detailed view of coverage, gene fusions and alternatively spliced isoforms. OncoLand contains a variety of modules for integrative analysis, comparisons, and clinical associations explorations. OncoLand has become an invaluable platform to accelerate successful cancer research and clinical innovations.


    Show Resources
    You May Also Like
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    DEC 02, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    AUG 25, 2020 8:00 AM PDT
    C.E. CREDITS
    AUG 25, 2020 8:00 AM PDT
    DATE: August 25, 2020 TIME: 8:00am PDT, 10:00am CDT, 11:00am EDT Recombinant lentivirus (LV) and adeno-associated virus (AAV) are critical components of cell and gene therapies, which show g...
    OCT 08, 2020 7:00 AM PDT
    C.E. CREDITS
    OCT 08, 2020 7:00 AM PDT
    DATE: October 8, 2020 TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop thinking about ho...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    OCT 29, 2020 6:00 AM PDT
    C.E. CREDITS
    OCT 29, 2020 6:00 AM PDT
    Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
    NOV 14, 2018 9:00 AM PST

    Accelerating Cancer Research and Clinical Innovations Using OncoLand

    Sponsored by: QIAGEN

    Specialty

    Cancer Research

    Dna Sequencing

    Personalized Medicine

    Clinical Diagnostics

    Immunity

    Biotechnology

    Immunotherapy

    Antibodies

    Flow Cytometry

    Immuno-Oncology

    Research

    Gene Expression

    Cancer Therapeutics

    Dna

    Big Data

    Geography

    North America33%

    Asia33%

    Europe33%

    Registration Source

    Website Visitors100%

    Job Title

    Student33%

    Facility/Department Manager33%

    Medical Laboratory Technician33%

    Organization

    Life Science Company33%

    Manufacturer - Other33%

    Academic Institution33%


    Show Resources
    Loading Comments...
    Show Resources
    Attendees
    • See more